Virax Biolabs Group Limited (VRAX) Options Chain

The options chain displays all available contracts with real-time quotes, Greeks, volume, and open interest for each strike and expiration. It is the primary tool for options trade selection.

Virax Biolabs Group Limited (VRAX) operates in the Healthcare sector, specifically the Biotechnology industry, with a market capitalization near $643,856, listed on NASDAQ, employing roughly 26 people, carrying a beta of 1.33 to the broader market. Virax Biolabs Group Limited is a biotechnology company focused on the detection of immune responses to and diagnosis of viral diseases. Led by James Foster, public since 2022-07-21.

The options chain displays all available contracts with quotes, Greeks, and open interest. No recent options activity for VRAX as of 2026-07-17; this typically reflects low options liquidity, a recently listed name, or a temporary data feed delay. Snapshot will refresh on the next active session.

Learn how the options chain is reported and how to read the data →